BioInvent International AB (publ) (0H22.IL)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Martin Welschof Ph.D. | Pres & CEO | 5.06M | -- | 1961 |
| Mr. Stefan Ericsson M.B.A. | Chief Financial Officer | -- | -- | 1963 |
| Ms. Marie Moores M.Sc., R.G.N. | Chief Operating Officer | -- | -- | -- |
| Mr. Kristoffer Rudenholm Hansson | Sr. VP of Technical Operations | -- | -- | 1974 |
| Mr. Bj?rn Frendéus | Chief Scientific Officer | -- | -- | 1973 |
| Ms. Cecilia Hofvander | Sr. Director of Investor Relations | -- | -- | 1967 |
| Dr. Andres McAllister | Chief Medical Officer | -- | -- | 1956 |
| Ms. Ingrid Teige | Head of Preclinical Research | -- | -- | -- |
| Ms. Sylvie Ryckebusch | Chief Bus. Officer | -- | -- | -- |
| Dr. Ingunn Munch Lindvig | Sr. VP of Regulatory Affairs | -- | -- | -- |
BioInvent International AB (publ)
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 103
Description
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. Its drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 for solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a partnership and collaboration with Transgene to co-develop BT-001 multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck to evaluate BT-001 in combination with Keytruda, and in BI-1808. BioInvent International AB (publ) was incorporated in 1996 and is based in Lund, Sweden.
Corporate Governance
Upcoming Events
October 31, 2024 at 7:00 AM UTC
BioInvent International AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available